Nature's Miracle Holding 株価情報 (NASDAQ: NMHI)

最新ニュース Nature's Miracle Holding (NASDAQ:NMHI) 株価情報

Nature's Miracle Holding

Nature's Miracle Holding Inc is a growing agriculture technology company providing Controlled Environment Agriculture (CEA) hardware products to growers in the CEA industry setting in North America. It provides hardware to design, build, and operate various indoor growing settings, including greenhouse and indoor growing spaces. Its products include Horticultural Lighting, Irrigation System, Power Distribution Systems, Climate Control Systems, Disinfection Systems, and Materials And Equipment.

Nature's Miracle Holding Inc. - Common Stock

Nature's Miracle Holding Inc

Innodata (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.13 by 169.23 percent. The company reported quarterly sales of $52.224 million which beat the analyst consensus estimate of $36.113 million by 44.61 percent. This is a 135.57 percent increase over sales of $22.169 million the same period last year.

Earnings

Earnings Beats

News

INOD

Innodata Q3 2024 Adj. EPS $0.35 Beats $0.13 Estimate, Sales $52.224M Beat $36.113M Estimate

Guidance

ABNB

Airbnb Sees Q4 2024 Revenue $2.39B-$2.44B Vs $3.717B Est.

Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.57) by 5.26 percent. This is a 39.33 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $28.07 million which beat the analyst consensus estimate of $28.02 million by 0.20 percent. This is a 26.41 percent increase over sales of $22.21 million the same period last year.

OUST

Ouster Q3 EPS $(0.54) Beats $(0.57) Estimate, Sales $28.07M Beat $28.02M Estimate

AFRM

Affirm Sees FY25 GMV OF More Than $34B

Accelerate Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXDX#NASDAQ">AXDX</a>) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.47) by 25.53 percent. This is a 1083.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $2.975 million which missed the analyst consensus estimate of $3.020 million by 1.49 percent. This is a 9.82 percent decrease over sales of $3.299 million the same period last year.

Earnings Misses

AXDX

Accelerate Diagnostics Q3 2024 GAAP EPS $(0.59) Misses $(0.47) Estimate, Sales $2.975M Miss $3.020M Estimate

Financial Outlook for Full Year 2024
The following tables summarize Getty Images' updated fiscal year 2024 guidance:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Updated 2024 Guidance</td>
<td>Prior 2024 Guidance</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Revenue</td>
<td>$934 million to $943 million</td>
<td>$924 million to $943 million</td>
</tr>
<tr>
<td>Revenue YoY</td>
<td>1.9% to 2.9%</td>
<td>0.9% to 2.9%</td>
</tr>
<tr>
<td>Revenue YoY, Currency Neutral</td>
<td>1.6% to 2.6%</td>
<td>1.0% to 3.0%</td>
</tr>
<tr>
<td>Adjusted EBITDA</td>
<td>$292 million to $294 million</td>
<td>$290 million to $294 million</td>
</tr>
<tr>
<td>Adjusted EBITDA YoY</td>
<td>(3.1)% to (2.5)%</td>
<td>(3.8)% to (2.5)%</td>
</tr>
<tr>
<td>Adjusted EBITDA YoY, Currency Neutral</td>
<td>(3.4)% to (2.8)%</td>
<td>(3.6)% to (2.3)%</td>
</tr>
</tbody>
</table>
</figure>
 Guidance has been updated to reflect the Company's financial performance year to date and the impact of foreign currency exchange rates on both Revenue and Adjusted EBITDA.

GETY

Getty Images Raises FY24 Revenue From $924M-$943M To $934M-$943M Vs $932.61M Est.

Affirm Sees Q2 Revenue $770M-$810M

CPAY

Corpay Narrows FY24 Total Revenue Outlook From $3.975B - $4.025B To $3.98B - $4.01B (Est $3.989B), Adjusted EPS Forecast From $18.85 - $19.15. To $18.90 - $19.10 (Est $18.96)

Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) narrows FY2024 sales outlook from $269.60 million-281.60 million to $272.60 million-278.60 million.

UPLD

Upland Software Narrows FY2024 Sales Guidance from $269.60M-281.60M to $272.60M-278.60M  VS Est.274.57M

Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.01 by 6.93 percent. The company reported quarterly sales of $112.716 million which beat the analyst consensus estimate of $110.552 million by 1.96 percent. This is a 414.00 percent increase over sales of $21.929 million the same period last year.

VINP

Vinci Partners Inv Q3 2024 Adj. EPS $1.08 Beats $1.01 Estimate, Sales $112.716M Beat $110.552M Estimate

Green Dot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.17 by 23.53 percent. The company reported quarterly sales of $406.019 million which beat the analyst consensus estimate of $392.579 million by 3.42 percent. This is a 16.48 percent increase over sales of $348.571 million the same period last year.

GDOT

Green Dot Q3 2024 Adj. EPS $0.13 Misses $0.17 Estimate, Sales $406.019M Beat $392.579M Estimate

Clearfield (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLFD#NASDAQ">CLFD</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.19) by 68.42 percent. This is a 135.29 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $46.77 million which beat the analyst consensus estimate of $41.95 million by 11.49 percent. This is a 5.86 percent decrease over sales of $49.69 million the same period last year.

CLFD

Clearfield Q4 EPS $(0.06) Beats $(0.19) Estimate, Sales $46.77M Beat $41.95M Estimate

Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) sees Q4 sales of $29.000 million-31.000 million vs $29.93 million estimate.

Ouster Sees Q4 Sales $29.000M-31.000M vs $29.93M Est

AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) is looking for Q4 Adj EPS of $0.18-0.19 vs $0.01 analyst estimate. sees sales of $9.700 million-9.800 million vs $9.47 million estimate.

AEYE

AudioEye Sees Q4 Adj EPS $0.18-0.19 vs $0.01 Est; Sees Sales $9.700M-9.800M vs $9.47M Est

Business Outlook
Gary Yu further commented, "For the fourth quarter of 2024, we expect revenue to be approximately $337 million, plus or minus 3 percent, representing a 3.7% sequential decrease at the mid-point, slightly better than typical seasonality. GAAP gross margin is expected to be 33.0 percent, plus or minus 1 percent. Non-GAAP operating expenses, which are GAAP operating expenses adjusted for amortization of acquisition-related intangible assets, are expected to be approximately 28.0 percent of revenue, plus or minus 1 percent. We expect net interest income to be approximately $2.5 million. Our income tax rate is expected to be 18.0 percent, plus or minus 3 percent, and shares used to calculate diluted EPS for the fourth quarter are anticipated to be approximately 46.7 million."
Amortization of acquisition-related intangible assets of $3.1 million, after tax, for previous acquisitions is not included in these non-GAAP estimates.

DIOD

Diodes Inc. Sees Q4 Revenue ~$337M +/- 3% Vs $351.74M Est.

AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) raises FY2024 Adj EPS guidance from $0.51-0.53 to $0.54-0.55 vs $(0.13) analyst estimate. Raises FY2024 sales outlook from $35.15 million-35.25 million to $35.20 million-35.30 million vs $34.93 million estimate.

AudioEye Raises FY2024 Adj EPS Guidance from $0.51-0.53 to $0.54-0.55 vs $(0.13) Est; Raises FY2024 Sales Guidance from $35.15M-35.25M to $35.20M-35.30M vs $34.93M Est

Lantern Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.56) by 25 percent.

LTRN

Lantern Pharma Q3 2024 GAAP EPS $(0.42) Beats $(0.56) Estimate

Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) sees Q4 sales of $65.900 million-71.900 million vs $67.71 million estimate.

Upland Software Sees Q4 Sales $65.900M-71.900M vs $67.71M Est

Dividends

VCTR

Victory Capital Holdings Increases Quarterly Cash Dividend From $0.41 To $0.44 Per Share

Tidewater (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) reported quarterly earnings of $0.87 per share which missed the analyst consensus estimate of $1.09 by 20.18 percent. This is a 77.55 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $340.40 million which missed the analyst consensus estimate of $345.55 million by 1.49 percent. This is a 13.75 percent increase over sales of $299.26 million the same period last year.

Tidewater Q3 EPS $0.87 Misses $1.09 Estimate, Sales $340.40M Miss $345.55M Estimate

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) stock is on the rise Tuesday alongside heavy pre-market trading of the agriculture technology company&rsquo;s shares.



This has more than 11 million shares of NMHI stock changing hands as of this writing. That&rsquo;s quite the surge compared to the company&rsquo;s daily average trading volume of about 82,000 shares. Its float is also <a href="https://finance.yahoo.com/quote/NMHI/key-statistics/">only 8.07 million units</a>.



There is no news from Nature&rsquo;s Miracle that explains why the stock is up today. However, it could be due to its connection to the cannabis market. It sells lighting and fixtures used by cannabis growers. That sector has been of interest lately with some seeing newly-announced presidential candidate Kamala Harris as <a href="https://www.usatoday.com/story/news/nation/2024/07/22/kamala-harris-marijuana-stance-policy/74495543007/">positive on marijuana legalization</a>.



It&rsquo;s also worth mentioning that NMHI is a penny stock. That comes from its low daily average trading volume, prior closing price of just 35 cents and its market capitalization of only $9.26 million.



<h2>What That Means for NMHI Stock</h2>



All of this shows that Nature&rsquo;s Miracle&rsquo;s shares are subject to volatility. This can happen as speculative traders pile into a company&rsquo;s stock. That might be happening this morning alongside the current Vice President securing the Democratic presidential candidate position.



NMHI stock is up 94.2% as of Tuesday morning.



Investors will want to stick around for more of the most recent stock market stories!



We have all of the hottest stock market news investors need to know about on Tuesday! Among that is what has shares of Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock up, the biggest pre-market stock movers this morning and more. All of that info is ready at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-warrantee-wrnt-stock-up-129-today/">Why Is Warrantee (WRNT) Stock Up 129% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Tuesday</a></li>



<li><a href="https://investorplace.com/2024/07/amc-stock-pops-on-news-company-will-restructure-debt/">AMC Stock Pops on News Company Will Restructure Debt</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature's Miracle (NMHI) Stock Up 94% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Nature's Miracle (NMHI) Stock Up 94% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
TransCode Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is taking a beating on Tuesday after the biopharmaceutical company announced the pricing for a public offering of its shares.



TransCode Therapeutics is <a href="https://www.nasdaq.com/press-release/transcode-therapeutics-inc-announces-pricing-public-offering-2024-07-22">selling 10 million shares</a> of its common stock for 30 cents each. This has it expecting to raise gross proceeds of $30 million from the public offering of RNAZ stock.



TransCode Therapeutics says it will use the money from this offering mostly for product development activities. That includes more clinical trials of TTX-MC138. This is its lead product candidate for the treatment of metastatic tumors.



<h2>What This Means for RNAZ Stock</h2>



A public offering increases the total number of outstanding shares on the market. That&rsquo;s a blow to current investors in RNAZ as it reduces their stakes in the company. This is one reason why TransCode Therapeutics&rsquo; stock is falling today.



On top of that, the public offering price is a significant discount over its prior closing price of 79 cents. It makes sense that the price of RNAZ stock would drop with it offering news shares for just 30 cents each.



RNAZ stock is down 62.1% as of Tuesday morning. That comes with about 1.4 million shares traded, as compared to a daily average of around 1.3 million shares.



Investors will want to stick around for more of the most recent stock market stories!



We have all of the hottest stock market news investors need to know about on Tuesday! A few examples include what&rsquo;s happening with shares of Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) and Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock, as well as the biggest pre-market stock movers this morning. All of this info is ready to go at the links below!



<h2>More Tuesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature&rsquo;s Miracle (NMHI) Stock Up 94% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-warrantee-wrnt-stock-up-129-today/">Why Is Warrantee (WRNT) Stock Up 129% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Tuesday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-transcode-therapeutics-rnaz-stock-down-62-today/">Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mira Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) stock is down on Tuesday as the clinical-stage pharmaceutical company&rsquo;s shares come off of a major rally on Monday.



Shares of MIRA stock closed out Monday&rsquo;s normal trading hours up 627.4%. That came alongside heavy trading with <a href="https://finance.yahoo.com/quote/MIRA/">more than 153 million shares traded</a>. For comparison, its daily average trading volume is about 3.2 million shares.



Mira Pharmaceuticals stock experienced this rally after releasing data from a <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">pre-clinical study of Ketamir-2</a>. This is the company&rsquo;s novel oral ketamine analog designed to treat neurological and neuropsychiatric disorders.



The big news here is that the results were positive. This has the company excited about the prospect of furthering the development of Ketamir-2 and submitting an investigational new drug (IND) application for it.



<h2>MIRA Stock Movement on Tuesday</h2>



Considering the massive rally MIRA shares underwent yesterday, it makes sense they would give up some of those gains in the days to follow. This has the stock dropping 27.4% as of Tuesday morning.



Today&rsquo;s dip comes with more than 5.5 million shares changing hands this morning. That&rsquo;s already above its daily average trading volume but is well below yesterday&rsquo;s heavy trading.



Investors who are seeking out even more of the most recent stock market stories today will want to keep reading!



We have all of the hottest stock market news that traders need to know about on Tuesday! That includes everything happening with shares of TransCode Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock, Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>)&nbsp;stock and Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock today. All of this info is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-transcode-therapeutics-rnaz-stock-down-62-today/">Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/trade-of-the-day-buy-sentinelone-s-stock-amid-cybersecurity-carnage/">Trade of the Day: Buy SentinelOne (S) Stock Amid Cybersecurity Carnage</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature&rsquo;s Miracle (NMHI) Stock Up 94% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-down-27-today/">Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!



Moving stocks this morning are earnings reports, a clinical trial update, acquisition news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing close to 121% <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">on a clinical trial update</a>.</li>



<li>BurgerFi International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) shares are soaring more than 93% <a href="https://www.nasdaq.com/press-release/burgerfi-reaches-legal-settlement-agreement-lion-point-capital-lp-2024-07-25">on a settlement agreement</a>.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is surging over 65% on a <a href="https://www.nasdaq.com/press-release/carbon-revolution-supplies-carbon-fiber-wheels-chevrolet-corvette-zr1-2024-07-25">supply deal with Chevrolet</a>.</li>



<li>Everi (NYSE:<a href="https://investorplace.com/stock-quotes/evri-stock-quote/">EVRI</a>) shares are gaining more than 35% <a href="https://www.nasdaq.com/press-release/igts-gaming-and-digital-business-and-everi-be-acquired-simultaneously-apollo-funds">on an acquisition deal</a>.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) stock is increasing over 26% with its <a href="https://www.businesswire.com/news/home/20240725452896/en/Coursera-Reports-Second-Quarter-2024-Financial-Results">latest earnings report</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are rising more than 24% alongside heavy pre-market trading.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is heading over 21% higher with strong early morning trading.</li>



<li>Nova Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVA#NASDAQ">NVA</a>) shares are climbing more than 20% <a href="https://www.tipranks.com/news/company-announcements/nova-minerals-issues-millions-of-new-warrants">after issuing new warrants</a>.</li>



<li>International Game Technology (NYSE:<a href="https://investorplace.com/stock-quotes/igt-stock-quote/">IGT</a>) stock is jumping over 20% alongside the <a href="https://www.prnewswire.com/news-releases/igts-gaming-and-digital-business-and-everi-to-be-acquired-simultaneously-by-apollo-funds-in-all-cash-transaction-302207429.html">Everi acquisition news</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are up more than 17% on Friday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is crashing more than 40% without any clear news this morning.</li>



<li>DexCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) shares are plummeting over 34% on <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">poor Q2 results and a cut outlook</a>.</li>



<li>Advent Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/adn-stock-quote/">ADN</a>) stock is diving more than 33% despite a lack of news this morning.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are tumbling over 30% after <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">rallying earlier this week</a>.</li>



<li>Zynex (NASDAQ:<a href="https://investorplace.com/stock-quotes/zyxi-stock-quote/">ZYXI</a>) stock is taking a nearly 23% beating with its <a href="https://www.nasdaq.com/press-release/zynex-reports-second-quarter-2024-financial-results-2024-07-25">Q2 earnings report</a>.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are sliding more than 22% <a href="https://www.nasdaq.com/press-release/ocean-power-technologies-inc-announces-fourth-quarter-and-full-year-fiscal-2024">alongside its latest earnings report</a>.</li>



<li>Renovaro (NASDAQ:<a href="https://investorplace.com/stock-quotes/renb-stock-quote/">RENB</a>) stock is dropping over 18% without any obvious news to report.</li>



<li>Avinger (NASDAQ:<a href="https://investorplace.com/stock-quotes/avgr-stock-quote/">AVGR</a>) shares are falling almost 15% this morning.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is decreasing 14% after rallying yesterday.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares close out our pre-market stock movers down more than 13.5% after jumping yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Nature's Miracle Holding stock plummets on pricing of $1.2M public offering

Nature's Miracle Holding (NMHI) has issued an announcement. On July 17, 2024, Nature's Miracle Holding Inc. sold a $180,000 convertible note and a ...

Nature's Miracle Holding Concludes Convertible Note Agreement

An update from Nature's Miracle Holding (NMHI) is now available. Nature's Miracle Holding Inc. has reached an agreement with Darin Carpenter for hi...

Nature's Miracle Holding Announces COO Transition and Stock Vesting

Nature's Miracle Holding GAAP EPS of -$0.07, revenue of $3.4M

Nature's Miracle enters debt reduction agreement with Uninet Global

Nature's Miracle (NMHI) announced it has entered into a Cooperation Agreement with Robostreet to order a total of 150 LS450 electric trucks from Ro...

Comments

Nature's Miracle Holding

ニュース

最新ニュース Nature's Miracle Holding (NASDAQ:NMHI) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル